Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Hong-Yi Xin"'
Autor:
Ying Liu, Yuanyi Huang, Hong-Wei Cui, YingYing Wang, ZhaoWu Ma, Ying Xiang, Hong-Yi Xin, Jun-Qing Liang, Hong-Wu Xin
Publikováno v:
Cancer Cell International, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Allogeneic tumors are eradicated by host immunity; however, it is unknown how it is initiated until the report in Nature by Yaron Carmi et al. in 2015. Currently, we know that allogeneic tumors are eradicated by allogeneic IgG via dendritic
Externí odkaz:
https://doaj.org/article/49d2faa1cfad4a319d7c9c3d57dbe2cd
Autor:
Xianwang Wang, Yihua Shen, Xingxia Wan, Xiaoqing Hu, Wen-Qi Cai, Zijun Wu, Qiang Xin, Xiaoqing Liu, Jingang Gui, Hong-Yi Xin, Hong-Wu Xin
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-36 (2023)
Abstract Background Oncolytic virotherapy (OVT) is a promising anti-tumor modality that utilizes oncolytic viruses (OVs) to preferentially attack cancers rather than normal tissues. With the understanding particularly in the characteristics of viruse
Externí odkaz:
https://doaj.org/article/ab05cd07335f4b07b6dd5398aa791721
Autor:
Xiao-Qin Liu, Hong-Yi Xin, Yan-Ning Lyu, Zhao-Wu Ma, Xiao-Chun Peng, Ying Xiang, Ying-Ying Wang, Zi-Jun Wu, Jun-Ting Cheng, Jia-Fu Ji, Ji-Xin Zhong, Bo-Xu Ren, Xian-Wang Wang, Hong-Wu Xin
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 1950-1962 (2018)
Oncolytic herpes simplex viruses (oHSVs) have been approved for clinical usage and become more and more popular for tumor virotherapy. However, there are still many issues for the oHSVs used in clinics and clinical trials. The main issues are the lim
Externí odkaz:
https://doaj.org/article/5446528df0374887be00a809495f5a83
Autor:
Qiang Xin, Yanlong Zhao, Shaoli Huang, Hong-Yi Xin, Zhipeng Feng, Hong-Wu Xin, Xiaoyan Wang, Yingying Wang, Xiulan Su
Publikováno v:
Oncologie.
Objectives Stomach adenocarcinoma (STAD) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. It is important to understand its molecular basis better and identify noninvasive biomarkers for targeted therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::398eb0fd9cf32c7657b6e75ee36049a2
https://doi.org/10.1515/oncologie-2023-0109
https://doi.org/10.1515/oncologie-2023-0109
Publikováno v:
Pattern Recognition. 141:109594
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1be49f2b56454a1f638a48090cb338b4
https://doi.org/10.1016/j.patcog.2023.109594
https://doi.org/10.1016/j.patcog.2023.109594
Autor:
Xian-Wang Wang, Xiao-Qin Liu, Yan-Ning Lyu, Ying-Ying Wang, Xiao-Chun Peng, Ying Xiang, Zhaowu Ma, Jun-Ting Cheng, Victoria W. Xin, Jiafu Ji, Cheng-Biao Lu, Yan-Fang Liang, Shuzhong Cui, Hong-Yi Xin, Bo-Xu Ren, Hong-Wu Xin
Publikováno v:
Journal of Cancer
An oncolytic herpes simplex virus (oHSV) has proven amenable in oncolytic virotherapy and was approved to treat melanoma. The immediate-early (IE) protein ICP27 encoded by gene UL54 is essential for HSV infection. Post-transcriptional modification of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a1a4ff48f69980fefe8e30d9737a28
https://doi.org/10.7150/jca.29787
https://doi.org/10.7150/jca.29787
Publikováno v:
Investigational new drugs. 39(3)
Breast cancer is the most diagnosed cancer in women. It significantly impairs a patient's physical and mental health. Gut microbiota comprise the bacteria residing in a host's gastrointestinal tract. Through studies over the last decade, we now know
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b91af6be4be76d869efeebca7ec49fd5
https://pubmed.ncbi.nlm.nih.gov/33454868
https://pubmed.ncbi.nlm.nih.gov/33454868
Autor:
Hong-Yi Xin, Jixin Zhong, Jun-Ting Cheng, Xiao-Qin Liu, Ying Xiang, Ying-Ying Wang, Hong-Wu Xin, Xiao-Chun Peng, Zi-Jun Wu, Xian-Wang Wang, Zhaowu Ma, Jiafu Ji, Yan-Ning Lyu, Boxu Ren
Publikováno v:
Drug Delivery, Vol 25, Iss 1, Pp 1950-1962 (2018)
Drug Delivery
Drug Delivery
Oncolytic herpes simplex viruses (oHSVs) have been approved for clinical usage and become more and more popular for tumor virotherapy. However, there are still many issues for the oHSVs used in clinics and clinical trials. The main issues are the lim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b98ad7378b81319780542f09e8824dda
https://doaj.org/article/5446528df0374887be00a809495f5a83
https://doaj.org/article/5446528df0374887be00a809495f5a83
Publikováno v:
Tumor Biology. 35:10051-10056
Recently, we reported that anticancer bioactive peptide (ACBP), purified from goat spleens immunized with human gastric cancer extracts, significantly inhibited gastric cancer cells in vitro and gastric tumors in vivo via repressing cell growth and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f91d5ba0da3baa6b76addc187ea4861
https://doi.org/10.1007/s13277-014-2272-7
https://doi.org/10.1007/s13277-014-2272-7
Autor:
Chan-Juan Shen, An-Chun Cheng, Ming-Shu Wang, Yu-Fei Guo, Li-Chan Zhao, Ming Wen, Wei Xie, Hong-Yi Xin, De-Kang Zhu
Publikováno v:
Archives of Virology; Jul2009, Vol. 154 Issue 7, p1061-1069, 9p, 1 Color Photograph, 2 Diagrams, 1 Chart, 3 Graphs